Pharma Pulse 3/17/25: Dual Trial Strategies, Executive Order Advances Price Transparency Efforts & more

Dual Trial Strategy: Company-Sponsored and Investigator-Initiated

Artiva Biotherapeutics' CEO Fred Aslan, MD, explains the strategic advantages of pursuing both a company-sponsored trial and an investigator-initiated trial simultaneously.

Executive Order Advances Price Transparency Efforts to Lower Health Care Costs

This marks steps toward improving health care pricing transparency, but further reforms are needed to reduce costs long-term.

JPMorgan Employee Lawsuit Says Bank Overpaid for Prescription Drugs

JPMorgan Chase & Co. was sued by employees who say the company’s prescription drug plan, run by CVS Health Corp., agreed to pay exorbitant prices for medications, driving up expenses for workers.

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer

AstraZeneca and Erin Andrews have teamed up as part of a national public health campaign to educate and empower people to Get Body Checked Against Cancer. Erin is a passionate entrepreneur, national sports broadcaster, podcast host, hockey fan and wife — and cancer survivor.

The Get Body Checked Against Cancer campaign encourages people to take control of their health by talking with their doctors about their cancer risk factors and whether cancer screenings are right for them. The campaign supports Hockey Fights Cancer™, a joint initiative of the National Hockey League and the National Hockey League Players’ Association powered by the V Foundation for Cancer Research.

@JamesChisum on X

New Survey Says Americans Choose Between Healthcare and Basic Necessities https://pharmexec.com/view/survey-americans-choose-healthcare-basic-necessities… via @PharmExec

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs